Zydus gets USFDA nod for Sugammadex Injection, 200 mg/2 mL and 500 mg/5 mL single-dose vial Read more
Zydus gets USFDA nod for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day Read more
Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients with comorbidities Read more
Eminence Business Media hosts sixth edition of Annual Pharma Project & Portfolio Management 2023 Read more
